Primordial prevention in myocardial infarction are all except –
**Question:** Primordial prevention in myocardial infarction are all except -
A. Diet and lifestyle modifications
B. Antihypertensive medications
C. Beta-blockers
D. Aspirin therapy
**Correct Answer:** .
**Core Concept:** Primordial prevention focuses on modifying risk factors in the general population or high-risk individuals to prevent the development of chronic diseases, such as myocardial infarction (MI). These preventive strategies aim to reduce the overall prevalence of risk factors and improve population health outcomes.
**Why the Correct Answer is Right:** Primordial prevention in the context of MI primarily targets modifying risk factors at a population level or in high-risk individuals. Diet and lifestyle modifications (option A) can be effective in preventing the development of risk factors, such as hypertension, dyslipidemia, and obesity, which are major contributors to MI.
**Why Each Wrong Option is Incorrect:**
A. Antihypertensive medications (option B) are usually involved in primary or secondary prevention strategies, focusing on managing hypertension and reducing the risk of MI in individuals with established hypertension or those at high risk for MI.
B. Beta-blockers (option C) are commonly used in the treatment of hypertension, angina, or heart failure. While they can have a role in secondary prevention of MI, they are not typically part of primordial prevention strategies.
D. Aspirin therapy (option D) is commonly used in secondary prevention of MI, reducing the risk of recurrent MI in individuals with a previous MI or coronary artery disease. In primordial prevention, aspirin therapy is not a primary focus.
**Clinical Pearl:** Primordial prevention plays a crucial role in reducing the burden of chronic diseases like MI on global health. By targeting modifiable risk factors through population-wide interventions and public health campaigns, we can prevent the development of MI in the general population. This approach is essential for improving overall population health and reducing healthcare costs associated with MI treatment.